The Journal of Experimental Medicine · 2000 · 209 citations · 26 references
Life SciencesGeneticsOncologyGene ExpressionMolecular OncologyOncogenesB Cell BiologyB Cell DevelopmentImmunoglobulin Gene RearrangementLymphoid NeoplasmsLymphoid TumorsMyc Family OncogenesB Lymphocyte DevelopmentImmunoglobulin Light Chain RearrangementLocus Control RegionsLymphoma PathogenesisMyc In Burkitt LymphomaMyc In LymphomaRegulatory SequencesTranslocation-associated Lymphomas
Chromosomal translocations juxtaposing the MYC protooncogene with regulatory sequences of immunoglobulin (Ig) H chain or kappa (Ig kappa) or lambda (Ig lambda) L chain genes and effecting deregulated expression of MYC are the hallmarks of human Burkitt lymphoma (BL). Here we report that lymphomas with striking similarities to BL develop in mice bearing a mutated human MYC gene controlled by a reconstructed Ig lambda locus encompassing all the elements required for establishment of locus control in vitro. Diffusely infiltrating lymphomas with a typical starry sky appearance occurred in multiple founders and an established line, indicating independence from positional effects. Monoclonal IgM(+)CD5(-)CD23(-) tumors developed from an initially polyclonal population of B cells. These results demonstrate that the phenotype of B lineage lymphomas induced by MYC dysregulation is highly dependent on cooperativity among the regulatory elements that govern expression of the protooncogene and provide a new system for studying the pathogenesis of BL.
26
Nancy L. Harris, Elaine S. Jaffe, J Diébold et al. · Journal of Clinical Oncology · 1999 · 3.3K citations
Medicine, Hematology, Pathology +17
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Jerry M. Adams, A. W. Harris, Carl A. Pinkert et al. · Nature · 1985 · 1.8K citations
Rebecca Taub, Ilan R. Kirsch, Cynthia C. Morton et al. · Proceedings of the National Academy of Sciences · 1982 · 1.4K citations · Full text